Bulk Manufacturer of Controlled Substances Application: Organix, Inc., 539 [2017-28180]
Download as PDF
<![CDATA[
539
Federal Register / Vol. 83, No. 3 / Thursday, January 4, 2018 / Notices
SOUTH DAKOTA
manufacturer of the following basic
classes of controlled substances:
Miner County
Wheeler Hotel, 101 N. Main St.,
MINNESOTA
Ramsey County
Church of St. Casimir—Catholic, 937 E.
Jessamine Ave., St. Paul, AD83000939
Authority: 60.13 of 36 CFR part 60
Dated: December 13, 2017.
J. Paul Loether,
Chief, National Register of Historic Places/
National Historic Landmarks Program and
Keeper, National Register of Historic Places.
[FR Doc. 2017–28467 Filed 1–3–18; 8:45 am]
BILLING CODE 4312–52–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA–392]
Bulk Manufacturer of Controlled
Substances Application: Organix, Inc.
ACTION:
Notice of application.
Registered bulk manufacturers of
the affected basic classes, and
applicants therefore, may file written
comments on or objections to the
issuance of the proposed registration on
or before March 5, 2018.
ADDRESSES: Written comments should
be sent to: Drug Enforcement
Administration, Attention: DEA Federal
Register Representative/DRW, 8701
Morrissette Drive, Springfield, Virginia
22152.
SUPPLEMENTARY INFORMATION: The
Attorney General has delegated his
authority under the Controlled
Substances Act to the Administrator of
the Drug Enforcement Administration
(DEA), 28 CFR 0.100(b). Authority to
exercise all necessary functions with
respect to the promulgation and
implementation of 21 CFR part 1301,
incident to the registration of
manufacturers, distributors, dispensers,
importers, and exporters of controlled
substances (other than final orders in
connection with suspension, denial, or
revocation of registration) has been
redelegated to the Assistant
Administrator of the DEA Diversion
Control Division (‘‘Assistant
Administrator’’) pursuant to section 7 of
28 CFR part 0, appendix to subpart R.
In accordance with 21 CFR
1301.33(a), this is notice that on
September 6, 2017, Organix, Inc., 240
Salem Street, Woburn, Massachusetts
01801 applied to be registered as a bulk
ethrower on DSK3G9T082PROD with NOTICES
DATES:
VerDate Sep<11>2014
16:16 Jan 03, 2018
Jkt 244001
Drug
code
Controlled substance
Additional documentation has been
received for the following resource:
Gamma Hydroxybutyric
Acid.
Lysergic acid
diethylamide.
Marihuana .......................
Tetrahydrocannabinols ...
Dimethyltryptamine .........
Psilocybin .......................
Psilocyn ..........................
Heroin .............................
Morphine .........................
Schedule
2010
I
7315
I
7360
7370
7435
7437
7438
9200
9300
I
I
I
I
I
I
II
The company plans to manufacture
reference standards for distribution to
its research and forensic customers. In
reference to drug code 7360 (marihuana)
and 7370 (THC) the company plans to
manufacture these drugs as synthetic.
No other activities for these drug codes
are authorized for this registration.
Dated: December 20, 2017.
Demetra Ashley,
Acting Assistant Administrator.
DC:llll llllllllllll
DCX:llll llllllllllll
Return to ODW—Mike Lewis
DCX:llll llllllllllll
DR:llll llllllllllll
DRX:llll llllllllllll
DRW:llll lllllllllll
DRW Policy Analyst:llll llll
DRG:llll llllllllllll
DRG/A:llll llllllllll
DRGR Unit Chief:llll llllll
DRQ:llll
lllllllllll
DRGR Staff Coordinatorllll lll
DRGR–L.Mckoyllll10/25/2017
NOA—ORGANIX INC
Document#: DRGR–17–0306
DFN: 010.02.A1 General
Correspondence
DFN: 301–04 Federal Register Files
[FR Doc. 2017–28180 Filed 1–3–18; 8:45 am]
BILLING CODE 4410–09–P
Controlled substance
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA–392]
Importer of Controlled Substances
Application: Sharp (Bethlehem), LLC
ACTION:
Notice of application.
Registered bulk manufacturers of
the affected basic classes, and
applicants therefore, may file written
comments on or objections to the
DATES:
PO 00000
Frm 00041
Fmt 4703
issuance of the proposed registration on
or before February 5, 2018. Such
persons may also file a written request
for a hearing on the application
pursuant on or before February 5, 2018.
ADDRESSES: Written comments should
be sent to: Drug Enforcement
Administration, Attention: DEA Federal
Register Representative/DRW, 8701
Morrissette Drive, Springfield, Virginia
22152. All requests for hearing must be
sent to: Drug Enforcement
Administration, Attn: Administrator,
8701 Morrissette Drive, Springfield,
Virginia 22152. All requests for hearing
should also be sent to: (1) Drug
Enforcement Administration, Attn:
Hearing Clerk/LJ, 8701 Morrissette
Drive, Springfield, Virginia 22152; and
(2) Drug Enforcement Administration,
Attn: DEA Federal Register
Representative/DRW, 8701 Morrissette
Drive, Springfield, Virginia 22152.
SUPPLEMENTARY INFORMATION: The
Attorney General has delegated his
authority under the Controlled
Substances Act to the Administrator of
the Drug Enforcement Administration
(DEA), 28 CFR 0.100(b). Authority to
exercise all necessary functions with
respect to the promulgation and
implementation of 21 CFR part 1301,
incident to the registration of
manufacturers, distributors, dispensers,
importers, and exporters of controlled
substances (other than final orders in
connection with suspension, denial, or
revocation of registration) has been
redelegated to the Assistant
Administrator of the DEA Diversion
Control Division (‘‘Assistant
Administrator’’) pursuant to section 7 of
28 CFR part 0, appendix to subpart R.
In accordance with 21 CFR
1301.34(a), this is notice that on June
15, 2017, Sharp (Bethlehem), LLC, 2400
Baglyos Circle, Bethlehem,
Pennsylvania 18020 applied to be
registered as an importer of the
following basic classes of controlled
substances:
Sfmt 4703
3,4-Methylenedioxy
methamphetamine.
Psilocybin .......................
Drug
code
Schedule
7405
I
7437
I
The company plans to import the
listed controlled substances for clinical
trials. No other activity for these drug
codes is authorized for this registration.
Approval of permits applications will
occur only when the registrant’s
business activity is consistent with what
is authorized under 21 U.S.C. 952(a)(2).
Authorization will not extend to the
import of FDA approved or non-
E:\FR\FM\04JAN1.SGM
04JAN1
]]>Agencies
[Federal Register Volume 83, Number 3 (Thursday, January 4, 2018)]
[Notices]
[Page 539]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2017-28180]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA-392]
Bulk Manufacturer of Controlled Substances Application: Organix,
Inc.
ACTION: Notice of application.
-----------------------------------------------------------------------
DATES: Registered bulk manufacturers of the affected basic classes, and
applicants therefore, may file written comments on or objections to the
issuance of the proposed registration on or before March 5, 2018.
ADDRESSES: Written comments should be sent to: Drug Enforcement
Administration, Attention: DEA Federal Register Representative/DRW,
8701 Morrissette Drive, Springfield, Virginia 22152.
SUPPLEMENTARY INFORMATION: The Attorney General has delegated his
authority under the Controlled Substances Act to the Administrator of
the Drug Enforcement Administration (DEA), 28 CFR 0.100(b). Authority
to exercise all necessary functions with respect to the promulgation
and implementation of 21 CFR part 1301, incident to the registration of
manufacturers, distributors, dispensers, importers, and exporters of
controlled substances (other than final orders in connection with
suspension, denial, or revocation of registration) has been redelegated
to the Assistant Administrator of the DEA Diversion Control Division
(``Assistant Administrator'') pursuant to section 7 of 28 CFR part 0,
appendix to subpart R.
In accordance with 21 CFR 1301.33(a), this is notice that on
September 6, 2017, Organix, Inc., 240 Salem Street, Woburn,
Massachusetts 01801 applied to be registered as a bulk manufacturer of
the following basic classes of controlled substances:
------------------------------------------------------------------------
Drug
Controlled substance code Schedule
------------------------------------------------------------------------
Gamma Hydroxybutyric Acid.............. 2010 I
Lysergic acid diethylamide............. 7315 I
Marihuana.............................. 7360 I
Tetrahydrocannabinols.................. 7370 I
Dimethyltryptamine..................... 7435 I
Psilocybin............................. 7437 I
Psilocyn............................... 7438 I
Heroin................................. 9200 I
Morphine............................... 9300 II
------------------------------------------------------------------------
The company plans to manufacture reference standards for
distribution to its research and forensic customers. In reference to
drug code 7360 (marihuana) and 7370 (THC) the company plans to
manufacture these drugs as synthetic. No other activities for these
drug codes are authorized for this registration.
Dated: December 20, 2017.
Demetra Ashley,
Acting Assistant Administrator.
DC:____----------------------------------------------------------------
DCX:____---------------------------------------------------------------
Return to ODW--Mike Lewis
DCX:____---------------------------------------------------------------
DR:____----------------------------------------------------------------
DRX:____---------------------------------------------------------------
DRW:____---------------------------------------------------------------
DRW Policy Analyst:____------------------------------------------------
DRG:____---------------------------------------------------------------
DRG/A:____-------------------------------------------------------------
DRGR Unit Chief:____---------------------------------------------------
DRQ:____---------------------------------------------------------------
DRGR Staff Coordinator____---------------------------------------------
DRGR-L.Mckoy____10/25/2017
NOA--ORGANIX INC
Document#: DRGR-17-0306
DFN: 010.02.A1 General Correspondence
DFN: 301-04 Federal Register Files
[FR Doc. 2017-28180 Filed 1-3-18; 8:45 am]
BILLING CODE 4410-09-P
